Upcoming Events
Future Treatment Innovations
The pace of innovation in hemophilia B has never been greater. From extended half-life therapies and rebalancing agents to gene therapy and emerging treatments still on the horizon, individuals and families are navigating more options than ever before.
Treatment Considerations for Women
The pace of innovation in hemophilia B has never been greater. From extended half-life therapies and rebalancing agents to gene therapy and emerging treatments still on the horizon, individuals and families are navigating more options than ever before.
A Closer Look at Hympavzi
The pace of innovation in hemophilia B has never been greater. From extended half-life therapies and rebalancing agents to gene therapy and emerging treatments still on the horizon, individuals and families are navigating more options than ever before.
A Blueprint for Confidence: Making Informed Choices in Hemophilia B With IDELVION
This educational presentation provides an overview of hemophilia B, including how bleeds occur, why even a single bleed can lead to long-term complications, and the importance of maintaining protective factor IX levels.
Innovation Lab: Gene and Cell Therapy
The pace of innovation in hemophilia B has never been greater. From extended half-life therapies and rebalancing agents to gene therapy and emerging treatments still on the horizon, individuals and families are navigating more options than ever before.
Innovation Lab: Rebalancing Agents
The pace of innovation in hemophilia B has never been greater. From extended half-life therapies and rebalancing agents to gene therapy and emerging treatments still on the horizon, individuals and families are navigating more options than ever before.
Hear directly from someone who has received gene therapy and learn more!
Hear directly from someone who has received gene therapy and learn more!
Innovation Lab: Understanding Inhibitor Treatment
The pace of innovation in hemophilia B has never been greater. From extended half-life therapies and rebalancing agents to gene therapy and emerging treatments still on the horizon, individuals and families are navigating more options than ever before.
Innovation Lab: Extended Half-Life Therapies
The pace of innovation in hemophilia B has never been greater. From extended half-life therapies and rebalancing agents to gene therapy and emerging treatments still on the horizon, individuals and families are navigating more options than ever before.
Innovation Lab: The History of Hemophilia B Treatment
The pace of innovation in hemophilia B has never been greater. From extended half-life therapies and rebalancing agents to gene therapy and emerging treatments still on the horizon, individuals and families are navigating more options than ever before.
Hemophilia B Product Landscape with Dr. David Clark
Understand your treatment options with Dr. David Clark!
Let’s Talk About a New Subcutaneous Prophylaxis Treatment for Hemophilia With and Without Inhibitors
Let’s Talk About a Subcutaneous Prophylaxis Treatment for Hemophilia With and Without Inhibitors
Hemophilia B Product Landscape with Dr. David Clark
Understand your treatment options with Dr. David Clark!
Hemophilia B Product Landscape with Dr. David Clark
Understand your treatment options with Dr. David Clark!
Living with Hemophilia B: From Challenges to Hopeful Futures
Living with Hemophilia B: From Challenges to Hopeful Futures
